MIRA INFORM REPORT

 

 

Report No. :

319503

Report Date :

29.04.2015

 

IDENTIFICATION DETAILS

 

Name :

SOFTGEL HEALTHCARE PRIVATE LIMITED

 

 

Registered Office :

Old No.7, New No.15, Gopalakrishnan Road, T. Nagar, Chennai – 600017, Tamilnadu

Tel. No.:

91-44-23452030

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

23.10.2003

 

 

Com. Reg. No.:

18-051829

 

 

Capital Investment / Paid-up Capital :

Rs.285.111 Million

 

 

CIN No.:

[Company Identification No.]

U24231TN2003PTC051829

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAHCS627L

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing of Pharmaceutical Products.

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (31)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 610000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track.

 

The company has recorded some accumulated losses from its operations.

 

However, trade relations are reported as fair. Business is active. Payments terms are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DENIED BY

 

Name :

Mrs. Patricia

Designation :

Financial Manager

Contact No.:

91-9380167063

Date :

27.04.2015

 

 

LOCATIONS

 

Registered Office :

Old No.7, New No.15, Gopalakrishnan Road, T. Nagar, Chennai – 600017, Tamilnadu, India

Tel. No. :

91-44-23452030-34

Mobile No. :

91-9380167063 (Mrs. Patricia)

Fax No. :

91-44-23452034 / 36

E-Mail :

accounts@softgelhealthcare.com

accounts@softgelhealthcare.com

deepak@softgelhealthcare.com

vijay@softgelhealthcare.com

Website :

http://softgelhealthcare.com

 

 

Factory :

Survey No:20/1, Vandalur - Kelambakkam Road, Pudupakkam Village - 603103, Kancheepuram, Tamilnadu, India

Tel. No. :

91-737-3251777, 3252777, 3253777

Fax No. :

91-44-2747 5857

 

 

DIRECTORS

 

AS ON 25.09.2014

 

Name :

Mr. Abdulhai Mohammed Sulaiman

Designation :

Managing director

Address :

Old No 16. New No 33/1, Kannadasan Road, T. Nagar, Chennai – 600017, Tamilnadu, India

Date of Birth/Age :

01.05.1951

Qualification :

B. Pharm

Date of Appointment :

23.10.2003

DIN No.:

01186491

 

 

Name :

Mr. Kannappan Nagappan

Designation :

Director

Address :

2nd The South Gate 35, Kasturi Ranga Road, Alwarpet, Chennai - 600018, Tamilnadu, India

Date of Birth/Age :

01.06.1952

Date of Appointment :

10.03.2014

DIN No.:

05216579

 

 

Name :

Mr. Krishnamurthy Balakumar

Designation :

Director

Address :

27A/11A, Moosa Street, T. Nagar, Chennai - 600017, Tamilnadu, India

Date of Birth/Age :

13.09.1952

Date of Appointment :

10.03.2014

DIN No.:

05215155

 

 

Name :

Mr. Alagappan

Designation :

Director

Address :

Plot 27/2, New Beach Road, Thiruvalluvar Nagar, Thiruvanmiyur, Chennai - 600041, Tamilnadu, India

Date of Birth/Age :

02.06.1953

Date of Appointment :

10.03.2014

DIN No.:

05215147

 

 

Name :

Mr. Sivasamy Manohar

Designation :

Director

Address :

25, Kamala Nagar, Madurai-625002, Tamil Nadu, India 

Date of Birth/Age :

15.03.1953

Date of Appointment :

26.09.2009

DIN No.:

01057515

 

 

Name :

Mr. A. Vijay Anand

Designation :

Whole-time Director

Address :

21/22, Lake Area 5th Creoss Street, Nugambakkam, Chennai – 600034, Tamilnadu, India

Date of Birth/Age :

24.03.1983

Date of Appointment :

17.09.2012

DIN No.:

06381968

 

 

Name :

Mr. Rajendran Patricea

Designation :

Whole-time director

Address :

No.18-B, Perumal Puram, Phase Iii, Puthur Village, Mappedu, Chennai - 600126, Tamilnadu, India

Date of Birth/Age :

31.07.1972

Date of Appointment :

23.02.2015

DIN No.:

07104652

 

 

Name :

Mr. Sampath Kumar

Designation :

Whole-time director

Address :

Old No. 6 New No. 8, Valmiki Street, Perungalathur, Chennai - 600063, Tamilnadu, India

Date of Birth/Age :

14.10.1959

Date of Appointment :

23.02.2015

DIN No.:

07104657

 

 

KEY EXECUTIVES

 

Name :

Mrs. Patricia

Designation :

Financial Manager

 

 

MAJOR SHAREHOLDERS

 

AS ON 25.09.2014

 

Names of Shareholders

 

No. of Shares

A.M. SuLaiman

650000

N. Meenakshy

1000000

B. Mangaleshwari

920000

A. L Gandhimathi

650000

S. Manohar

610000

Doppler Scan

100000

Maral Labs

2665000

The Madras Pharmaceuticals

9195000

Alagappan

800000

S. Humayun

800000

B. Vijay

530000

Nagappan

450000

M Chitra

740000

Balajadia Zenaida Dizon

9401074

 

 

Total

28511074

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 25.09.2014

 

Category

Percentage

Foreign holdings [Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others]

33.00

Directors or relatives of Directors

67.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of Pharmaceutical Products.

 

 

Products :

Item Code No. (ITC Code)

Product Description

99884300

Pharmaceutical Product Manufacturing Service

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

·         Pharmacy and Poisons Board Kenya

·         National Drug Authority Uganda

·         Ministry of Health Ukraine

·         Tanzania Food and Drug Agency Tanzania

·         Health Product and Food Branch Directorate Canada

·         National Agency for Food and Drug Administration and control ( NAFDAC) Nigeria

·         Bureau of Foods and Drug Authority Philippines

·         Ministry of Health Sri Lanka

·         Pharmacy Medicines and Poisons Board Malawi

·         Medicines and Healthcare products Regulatory Agency United Kingdom

·         Department of Health and Ageing Therapeutic goods

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

 

PRODUCTION STATUS – NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Company Name :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark :

Not Divulged

 

 

Customers :

Company Name :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark :

Not Divulged

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

Banker Name :

DBS Bank

Branch :

806, Anna Salai  Chennai – 600002, Tamilnadu, India

Person Name (With Designation) :

Not Divulged

Contact Number :

Not Divulged

Name of Account Holder :

Not Divulged

Account Number :

Not Divulged

Account Since (Date/Year of Account Opening) :

Not Divulged

Average Balance Maintained :

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan) :

Not Divulged

Account Operation :

Not Divulged

Remark :

Not Divulged

 

·         Indian Overseas Bank, C and IC Branch, 98A Dr. Radhakrishnan Salai, Mylapore, Chennai – 600004, Tamilnadu, India

 

 

Facilities :

SECURED LOANS

31.03.2014

Rs. In Million

31.03.2013

Rs. In Million

Long Term Borrowings

 

 

Rupee term loans from banks

3.061

14.913

Other loans and advances

1.001

1.489

 

 

 

Short Term Borrowings

 

 

Loans repayable on demand

134.805

130.520

 

 

 

Total

138.867

146.922

 

 

 

Auditors :

 

Name :

N Rajaraman and Associates

Chartered Accountants

Address :

No.100, 1st Floor, 3rd Cross Street, Sundar Nagar, Guindy, Chennai – 600032, Tamilnadu, India

PAN No. :

AAAFR5096B

 

 

Collaborators :

Not Divulged

 

 

Membership :

Not Divulged

 

 

Associates :

·         The Madras Pharma

·         Accent Pharma

·         Maral Labs

·         Steril-Gene Life Sciences Private Limited

·         Lloyd Laboratories Inc

·         Ristar Formulations Private Limited

·         Ocean Health and Medical Private Limited

·         Anphar Organics Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 25.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

30000000

Equity Shares

Rs.10/- each

Rs.300.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

28511074

Equity Shares

Rs.10/- each

Rs.285.111 Million

 

 

 

 

 


FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

285.111

285.111

285.111

(b) Reserves & Surplus

(71.794)

(90.077)

(111.386)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

213.317

195.034

173.725

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

50.704

28.178

47.892

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

50.704

28.178

47.892

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

134.805

130.520

77.316

(b) Trade payables

137.623

107.970

114.255

(c) Other current liabilities

35.314

44.909

67.090

(d) Short-term provisions

13.240

8.489

5.935

Total Current Liabilities (4)

320.982

291.888

264.596

 

 

 

 

TOTAL

585.003

515.100

486.213

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

220.282

230.652

232.109

(ii) Intangible Assets

0.912

0.835

0.000

(iii) Capital work-in-progress

0.000

1.774

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

5.787

8.146

14.381

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

226.981

241.407

246.490

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

121.209

92.048

114.022

(c) Trade receivables

220.528

161.529

92.899

(d) Cash and cash equivalents

2.486

7.355

3.963

(e) Short-term loans and advances

2.309

2.391

13.406

(f) Other current assets

11.490

10.370

15.433

Total Current Assets

358.022

273.693

239.723

 

 

 

 

TOTAL

585.003

515.100

486.213

 

 

PROFIT & LOSS ACCOUNT

                       

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

REVENUE FROM OPERATIONS & OTHER INCOME

535.565

549.347

451.692

 

 

 

 

 

Less

EXPENSES

474.201

476.818

381.246

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

61.364

72.529

70.446

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

14.023

24.163

27.32

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

47.341

48.366

43.126

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION        

29.756

27.755

24.131

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

17.585

20.611

18.995

 

 

 

 

 

Less

TAX                                                                 

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

17.585

20.611

18.995

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

0.62

0.72

0.66

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Return on Total Assets

(PBT/Total Assets)

(%)

3.01

4.02

3.91

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.08

0.11

0.11

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.87

0.81

0.72

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.12

0.94

0.91

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Share Capital

285.111

285.111

285.111

Reserves & Surplus

(111.386)

(90.077)

(71.794)

Net worth

173.725

195.034

213.317

 

 

 

 

long-term borrowings

47.892

28.178

50.704

Short term borrowings

77.316

130.520

134.805

Total borrowings

125.208

158.698

185.509

Debt/Equity ratio

0.721

0.814

0.870

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Revenue from operations & other income

451.692

549.347

535.565

 

 

21.620

(2.509)

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Revenue from operations & other income

451.692

549.347

535.565

Profit

18.995

20.611

17.585

 

4.21%

3.75%

3.28%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

REVIEW OF OPERATIONS:

 

The year has shown a marginal reduction in sale by 2.51%.

 

 

OUTLOOK:

 

Registration process of our products is going on in many countries like Iran, Vietnam, Mexico, Panama, Coasta Rica, Ukraine etc.

 

They have been exporting our products to IDA foundation (Netherlands), Forum Products (United Kingdom), South American Express (Bolivia), Medical International Laboratories, (Chile) in the year.

 

On the domestic front, during the current year, they have done business with a few reputed pharmaceutical companies like Intas Pharmaceuticals Private Limited, Indus Pharmaceuticals Private Limited, Apex Laboratories, FDC Limited, Ranbaxy Laboratories Limited, Orbit Life Science Private Limited, Medreich Limited, Amway India Enterprises Private Limited etc. They are taking utmost care in initiating business with the companies which have good annual requirements and are ready to pay.

 

 

UNSECURED LOANS:

 

Particulars

31.03.2014

Rs. In Million

31.03.2013

Rs. In Million

Long Term Borrowings

 

 

Loans and advances from related parties

46.642

9.276

Other loans and advances

0.000

2.500

 

 

 

Total

46.642

11.776

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10496493

28/04/2014 *

7,000,000.00

DBS Bank Limited

806, Anna Salai, Chennai, Tamil Nadu - 600002, India

C05406889

2

10413090

28/04/2014 *

23,080,000.00

DBS Bank Limited

806, Anna Salai, Chennai, Tamil Nadu - 600002, India

C05088232

3

10413108

28/04/2014 *

157,500,000.00

DBS Bank Limited

806, Anna Salai, Chennai, Tamil Nadu - 600002, India

C05406335

 

*Date of modification Charges

 

 

 

 

FIXED ASSETS:

 

·         Land

·         Factory Building

·         Computer

·         Furniture and Fittings

·         Office Equipments

·         Plant and Machinery

·         Vehicles

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.33

UK Pound

1

Rs.96.52

Euro

1

Rs.68.93

 

 

INFORMATION DETAILS

 

Information Gathered by :

KMN

 

 

Analysis Done by :

SUB

 

 

Report Prepared by :

NKT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILITY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

4

--RESERVES

1~10

3

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

31

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.